KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.30 $2.47 Friday, 26th Apr 2024 AKBA stock ended at $1.34. This is 0.752% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.25% from a day low at $1.30 to a day high of $1.35.
90 days $1.30 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Sep 23, 2021 $2.83 $2.91 $2.77 $2.91 1 377 765
Sep 22, 2021 $2.82 $2.89 $2.80 $2.81 974 513
Sep 21, 2021 $2.81 $2.90 $2.80 $2.85 1 182 340
Sep 20, 2021 $2.79 $2.91 $2.76 $2.80 2 194 177
Sep 17, 2021 $2.81 $2.91 $2.73 $2.90 4 996 384
Sep 16, 2021 $2.76 $2.83 $2.70 $2.82 1 099 260
Sep 15, 2021 $2.77 $2.83 $2.72 $2.78 1 459 776
Sep 14, 2021 $2.92 $2.95 $2.75 $2.75 1 966 533
Sep 13, 2021 $2.88 $3.00 $2.84 $2.92 1 873 446
Sep 10, 2021 $3.02 $3.02 $2.88 $2.88 1 321 506
Sep 09, 2021 $2.97 $3.06 $2.93 $2.95 1 793 185
Sep 08, 2021 $3.01 $3.03 $2.89 $2.94 1 638 700
Sep 07, 2021 $3.05 $3.13 $2.95 $2.98 1 429 109
Sep 03, 2021 $3.09 $3.10 $2.95 $3.03 2 755 959
Sep 02, 2021 $3.06 $3.15 $3.01 $3.14 3 134 904
Sep 01, 2021 $2.92 $3.07 $2.92 $3.05 2 753 125
Aug 31, 2021 $2.83 $2.99 $2.82 $2.94 2 445 756
Aug 30, 2021 $2.79 $2.90 $2.78 $2.82 1 977 478
Aug 27, 2021 $2.65 $2.87 $2.62 $2.85 3 668 200
Aug 26, 2021 $2.68 $2.77 $2.60 $2.61 1 610 311
Aug 25, 2021 $2.63 $2.74 $2.57 $2.68 1 615 271
Aug 24, 2021 $2.70 $2.74 $2.57 $2.61 1 545 710
Aug 23, 2021 $2.56 $2.69 $2.51 $2.66 2 294 637
Aug 20, 2021 $2.36 $2.52 $2.36 $2.51 2 306 377
Aug 19, 2021 $2.43 $2.49 $2.35 $2.35 3 213 542
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT